Latest Levitra news
Melanoma Risk Up Slightly With PDE5 Inhibitors
posted June 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
The small apparent increase in risk of melanoma in men prescribed phosphodiesterase type 5 inhibitors may be explained by greater sun exposure, according to new research published online June 14 in PLOS Medicine.
Editor's Recommendations
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors .jpg)
Tadalafil Linked to Glaucoma in Men With Lower Urinary Tract Symptoms 
1 in 3 Women and 1 in 4 Men Engage in Intentional Outdoor Tanning 
Melanoma Incidence and Deaths Disproportionately Impact Men Related Articles
Female Emergency Medicine Physicians Order More Tests, Admit More Patients .jpg)
Remote Patient-Reported Outcome Monitoring Empowers Patients With Cancer 
65.8 Percent of U.S. Counties Lack Radiation Oncology Practice Site .jpg)
Men More Likely to Be Diagnosed at Regional, Distant Cancer Staging Monthly Specialist Briefings
Stay Connected
